phrykt

Tandem Diabetes Care Inc (TNDM): who owns it and who trades it

As of Nov 16, 2026, TNDM insiders reported 3 open-market sales worth $36.9K and no purchases in the last 12 months, with 88% of the sale value made under pre-set 10b5-1 plans. The largest seller was Christopher J Twomey (Director), with $32.6K. 4 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Tandem Diabetes Care

From the latest filings

Overall: more buying than selling. Insiders mostly sold. Famous investors and Congress mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns TNDM

273 funds and institutions reported TNDM shares worth $1.2B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 16.9%.

Funds and institutions (13F) about 100%Everyone else 0%

10 largest owners, by share of the company

BlackRock, Inc.16.9%
Sessa Capital IM, L.P.7.4%
Vanguard Portfolio Management LLC6.3%
First Light Asset Management, LLC4.9%
Vanguard Capital Management LLC4.5%
State Street Corp4.2%
GW&K Investment Management, LLC3.7%
Jennison Associates LLC3.4%
Paradice Investment Management LLC3.0%
Jacobs Levy Equity Management, Inc2.9%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.11.58M16.90%$175M+8%
Sessa Capital IM, L.P.5.10M7.44%$77M+8%
Vanguard Portfolio Management LLC4.30M6.27%$64.9M+8%
First Light Asset Management, LLC3.38M4.94%$51.1M+157%
Vanguard Capital Management LLC3.10M4.52%$46.7M+2%
State Street Corp2.85M4.16%$43M+7%
GW&K Investment Management, LLC2.57M3.75%$38.8M-4%
Jennison Associates LLC2.33M3.40%$35.2M+41%
Paradice Investment Management LLC2.02M2.95%$30.5M-1%
Jacobs Levy Equity Management, Inc2.01M2.93%$30.3M+32%
Freestone Grove Partners LP1.87M2.72%$28.2M+40%
Geode Capital Management, LLC1.80M2.63%$27.2M+7%
Driehaus Capital Management LLC1.79M2.61%$27M-22%
Citadel Advisors LLC1.74M2.53%$26.2M-21%
Millennium Management LLC1.31M1.91%$19.8M+72%
Woodline Partners LP1.31M1.91%$19.7M–
ArrowMark Colorado Holdings LLC1.30M1.90%$19.6M-58%
UBS Group AG1.15M1.67%$17.3M-44%
FMR LLC (Fidelity)976,4321.42%$14.7M+37%
Royce & Associates LP900,5901.31%$13.6M+29%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, TNDM insiders reported $0 of open-market purchases and $36.9K of sales. 88% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$36.9K
3 trades, 2 people
Sales under a 10b5-1 plan
88%
Share of sale value
Latest trade
Oct 27, 2026
Filed Oct 29, 2026

Purchases and sales by month

$32.6K$32.6KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Oct 27, 2026Christopher J TwomeyDirectorSale plan1,700$19.15$32.6KForm 4
Mar 17, 2026Mark David NovaraVice presidentSale187$23.05$4.3KForm 4
Mar 5, 2026Mark David NovaraVice presidentSale plan2$22.81$46Form 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Christopher J TwomeyDirector–$32.6KOct 27, 2026
Mark David NovaraEVP & CHIEF COMMERCIAL OFFICER–$4.4KMar 17, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

TNDM short interest

Very high short interest. 23.2% of TNDM shares are sold short: about 1 share in 4. Over the last 12 reports the number of shares short went up 50%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 16.17M TNDM shares were sold short, 23.2% of the shares outstanding, up 7.2% from the report before. At the average daily volume of 2.12M shares, buying them all back would take about 7.6 trading days (days to cover).

Shares short, % of all shares

23.2%May 15Oct 3024.4%

Days to cover

7.6May 15Oct 309.5

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202616.17M23.24%+7%2.12M7.6
Oct 15, 202615.09M21.68%+13%2.20M6.9
Sep 30, 202613.37M19.21%+7%2.55M5.2
Sep 15, 202612.47M17.93%+6%1.58M7.9
Aug 31, 202611.75M16.89%+11%1.44M8.2
Aug 14, 202610.59M15.21%-6%2.72M3.9
Jul 31, 202611.24M16.41%-14%1.71M6.6
Jul 15, 202613.12M19.14%+3%1.50M8.7
Jun 30, 202612.73M18.58%+17%2.26M5.6
Jun 15, 202610.85M15.84%-8%2.66M4.1
May 29, 202611.79M17.20%+9%2.84M4.2
May 15, 202610.80M15.76%+11%3.22M3.4

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded TNDM

Since Nov 17, 2024, 2 members of Congress reported 4 purchases and 1 sale of TNDM. The latest was a purchase by Gilbert Ray Cisneros, Jr. on Sep 29, 2026, reported Oct 12, 2026.

Purchases 4Sales 1

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Sep 29, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfOct 12, 2026Report
Mar 3, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfApr 7, 2026Report
Sep 22, 2025Josh Gottheimer (D-NJ)Purchase$1K–$15KJointOct 15, 2025Report
Mar 19, 2025Josh Gottheimer (D-NJ)Sale$1K–$15KJointApr 10, 2025Report
Mar 4, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfApr 7, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Tandem Diabetes Care company events

Tandem Diabetes Care filed 8 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Nov 5, 2026.

  1. Nov 5, 2026ResultsReleased financial results. Filing
  2. Aug 6, 2026ResultsReleased financial results. Filing
  3. May 21, 2026LeadershipAt the Annual Meeting, the Company’s stockholders also approved the Company’s 2023 Long-Term Incentive Plan, as amended, to, among other things, increase the number of shares of the Company’s common stock (Common Stock) authorized for issuance under the plan by 3,260,000 shares (as so amended, the… Filing
  4. May 15, 2026LeadershipMark Novara, the Executive Vice President and Chief Commercial Officer of Tandem Diabetes Care, Inc., was notified that his employment with the Company is being terminated without cause. Filing
  5. May 7, 2026ResultsReleased financial results. Filing
  6. Feb 27, 2026AgreementEntry into a Material Agreement. Filing
  7. Feb 19, 2026ResultsReleased financial results. Filing
  8. Dec 30, 2025RulesChanged its bylaws or articles. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Tandem Diabetes Care financials

Famous investors that hold TNDM

4 of the 50 well-known investors we track reported holding TNDM in their latest 13F filing. The largest position is Israel Englander's, worth $33.8M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 20262.07M$33.8M0.0%+58%
Ken Griffin · Citadel AdvisorsQ3 20261.86M$30.4M0.0%+7%
Steve Cohen · Point72 Asset ManagementQ3 2026880,196$14.4M0.0%+44%
Paul Tudor Jones · Tudor Investment CorpQ3 2026432,816$7.1M0.0%+19%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 6 filings named TNDM in the last 120 days.

FiledHolderFormStake
Nov 16, 2026BALYASNY ASSET MANAGEMENT L.P.13G5.2%
Nov 16, 2026BALYASNY ASSET MANAGEMENT L.P.13G5.2%
Nov 16, 2026Sessa Capital IM, L.P.13G/A0.6%
Nov 16, 2026Sessa Capital IM, L.P.13G/A0.6%
Nov 9, 2026THE GOLDMAN SACHS GROUP, INC.13G5.9%
Nov 9, 2026THE GOLDMAN SACHS GROUP, INC.13G5.9%

Questions about Tandem Diabetes Care Inc (TNDM) stock

Who owns the most TNDM stock?

The largest reported owner of Tandem Diabetes Care Inc (TNDM) is BlackRock, Inc., with 16.9% of the company. In total, 273 funds and institutions reported holding TNDM at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are TNDM insiders buying or selling?

In the last 12 months, TNDM insiders reported no open-market purchases and 3 sales worth $36.9K. The latest trade was on Oct 27, 2026. See every trade.

What is the short interest in TNDM?

As of Oct 30, 2026, 16.17M TNDM shares were sold short, 23.2% of the shares outstanding, up 7.2% from the report before. At the average daily volume of 2.12M shares, buying them all back would take about 7.6 trading days (days to cover). See the history.

Have members of Congress traded TNDM?

Yes. 2 members of Congress reported 4 purchases and 1 sale of TNDM since Nov 17, 2024. The latest was reported on Oct 12, 2026. See the trades.

Which famous investors hold TNDM?

4 of the 50 well-known investors we track reported TNDM in their latest 13F filing, including Israel Englander, Ken Griffin, Steve Cohen. The largest position is worth $33.8M. See all holders.

Executive pay

Tandem Diabetes Care's chief executive was paid a total of $6.9M for the year ended Dec 31, 2025, down 20% from $8.5M the year before. In the last 12 months, Tandem Diabetes Care's executives and directors bought no stock on the open market and sold $36.9K.

Chief executive, total pay$6.9MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$2.9MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$2MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.